title: [The risk of malignancy after organ transplantation].
abstract: Improvements in immunosuppressive therapy during the past decade brought about improvements of the long term tolerance of organ allografts. However, the long-term immunosuppressive therapy has an important limitation, because it can increase the risk of cardivascular diseases, infections and tumors. As compared with age-matched healthy population, organ-transplant recipients have an increased incidence of tumors.
authors.affiliation: Klinika transplantacní chirurgie IKEM, Praha. robert.gurlich@ikem.cz
authors.forename: R
authors.initials: R
authors.lastname: Gürlich
authors.forename: J
authors.initials: J
authors.lastname: Novotný
authors.forename: I
authors.initials: I
authors.lastname: Stríz
authors.forename: E
authors.initials: E
authors.lastname: Honsová
authors.forename: M
authors.initials: M
authors.lastname: Oliverius
authors.forename: L
authors.initials: L
authors.lastname: Janousek
authors.forename: E
authors.initials: E
authors.lastname: Pokorná
authors.forename: P
authors.initials: P
authors.lastname: Maruna
mesh_terms: D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D009369:Neoplasms / Q000209:etiology*; D016377:Organ Transplantation / Q000009:adverse effects*; D012307:Risk Factors; D014181:Transplantation Immunology
chemical_list: D007166:Immunosuppressive Agents